TL;DR
This paper introduces XA4C, a novel method that uses explainable autoencoders to identify "Critical genes" from gene expression data. These Critical genes offer new biological insights beyond traditional methods and show strong relevance to disease pathology, particularly in cancer.
What Problem Does This Paper Address?
Analyzing gene expression data, especially from complex diseases like cancer, often involves machine learning (ML) models. Autoencoders (AEs), a type of representation learning (RL) model, are good at finding meaningful patterns in noisy data by learning "latent variables." However, these learned representations are typically black boxes, making it hard to pinpoint specific genes that are driving these patterns or are functionally important. Traditional methods like identifying differentially expressed (DiffEx) or co-expressed (DiffCoEx) genes, or "Hub" genes in networks, capture only marginal effects or simple correlations, potentially missing more complex, non-linear interactions. This lack of interpretability hinders the practical application of powerful RL models for identifying key biological players.
Methods
The core of this work is the XA4C (eXplainable Autoencoder for Critical genes) tool. It combines two main components:
- Explainable Autoencoders: XA4C uses autoencoders to learn compressed representations (latent variables) of gene expression data. The novelty here lies in making these AEs "explainable."
- SHAP for Gene Contribution: To understand which genes contribute most to these learned latent variables, XA4C employs eXplainable Artificial Intelligence (XAI) techniques, specifically SHAP (SHapley Additive exPlanations). SHAP values are used to quantify each gene's contribution to each latent variable.
XA4C then aggregates these SHAP values to compute a "Critical index" for each gene. Genes with the highest Critical indexes are identified as "Critical genes." The authors also developed both whole-transcriptome AEs and pathway-specific AEs.
Datasets
The study utilized gene expression data from The Cancer Genome Atlas (TCGA) for six different cancer types:
- Breast invasive carcinoma (BRCA)
- Colon adenocarcinoma (COAD)
- Kidney renal clear cell carcinoma (KIRC)
- Lung adenocarcinoma (LUAD)
- Prostate adenocarcinoma (PRAD)
- Thyroid carcinoma (THCA)
The raw count data was processed into Transcripts Per Million (TPM) matrices.
Key Insights and Ideas
- "Critical Genes" as a New Paradigm: The introduction of "Critical genes" provides a novel way to interpret RL models by directly linking learned representations back to individual genes. This offers a new perspective beyond traditional gene prioritization methods.
- Beyond Marginal Effects: Critical genes capture complex, non-linear gene interactions that are missed by DiffEx (marginal effects) and DiffCoEx/Hub genes (correlations).
- Disease Relevance: Critical genes show a significantly higher enrichment in disease gene databases like DisGeNET, suggesting they play crucial functional roles in disease pathology.
- Novelty in Cancer Pathways: Critical genes often have low overlap with DiffEx and Hub genes, indicating they highlight previously unrecognized biological mechanisms.
- Distinct Interaction Patterns: Critical genes can reveal distinct co-expression network patterns between tumor and normal tissues, even for genes not identified by traditional methods.
Key Results
- High Reconstruction Accuracy: Whole-transcriptome AEs with a high compression ratio (32 latent variables) achieved good reconstruction accuracy (R² values from 0.42-0.69), comparable to AEs with many more latent variables.
- Low Overlap with Traditional Methods: Critical genes showed poor overlap with Hub genes (identified by WGCNA) and DiffEx genes across all six cancers.
- Superior Disease Gene Enrichment: Critical genes demonstrated significantly higher enrichment in the DisGeNET database compared to Hub and DiffEx genes.
- Pathway Insights: Pathway enrichment analysis revealed that Critical genes are associated with key cancer-related pathways like oxidative phosphorylation and glutathione metabolism.
- Example in Lysine Degradation: In the Lysine degradation pathway, Critical genes were identified that displayed distinct interaction patterns in tumor vs. normal tissues, highlighting their role in disease pathogenesis.
Limitations and Future Work
The authors acknowledge several limitations and suggest future directions:
- AE Architecture Optimization: While they tested several AE configurations, a more comprehensive approach like Bayesian Hyperparameter Optimization could further refine architectures.
- Expanding AE Types: The study primarily used conventional AEs. Future work could explore Variational AEs for causal inference or Graph AEs for learning causal structures.
- SHAP Explainer Efficiency: For neural network models, more advanced SHAP explainers like DeepSHAP might be more efficient than TreeSHAP.
- Sample Heterogeneity: The current Critical index summarizes SHAP values across all samples, ignoring individual sample heterogeneity. Future work will focus on uncovering individualized Critical genes for precision medicine.
- Multi-omics Integration: XA4C currently supports only transcriptome data. Integrating additional omics data, such as proteomics and metabolomics, is a natural extension.
Summary updated